On ٠٦ نوفمبر ٢٠٢٥, DNA reported earnings of -1.45 USD per share (EPS) for Q3 25, missing the estimate of -1.25 USD, resulting in a -15.78% surprise. Revenue reached 38.84 مليون, compared to an expected 39.24 مليون, with a -1.02% difference. The market reacted with a -20.80% price change (close before vs. close after earnings).
Looking ahead to -- --, -- المحللين forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.